<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04672889</url>
  </required_header>
  <id_info>
    <org_study_id>201703031RINC</org_study_id>
    <nct_id>NCT04672889</nct_id>
  </id_info>
  <brief_title>Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis</brief_title>
  <official_title>Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TCI Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TCI Co., Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to understand the life history of the breast milk flora, explore its composition,&#xD;
      source of strains, and ability to colonize the baby's intestinal environment, to find out&#xD;
      strains with the potential of probiotics in breast milk&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a double-blind and randomized study. After being discharged from the hospital, the&#xD;
      subject was notified to consume the Babyguard breast milk probiotic daily for 1 month, and&#xD;
      observe whether the mother's stool, breast milk and baby stool samples can find the same&#xD;
      strain. The clinical diagnosis items of the bacterial strains of mother feces, breast milk&#xD;
      and baby feces samples are evaluated by the doctor.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microflora of mother's feces</measure>
    <time_frame>4-6 weeks after the baby is born</time_frame>
    <description>Collect mother's feces for bacterial analysis.The mother's feces use Qiagen stool mini kit to extract DNA, and then use the intestinal bacteria primers to detect the presence of intestinal bacteria in the feces.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Group. B Streptococcus (GBS) screening</measure>
    <time_frame>35-37 weeks of pregnancy</time_frame>
    <description>Use sterile cotton sticks for vaginal samples, and then perform Group. B Streptococcus (GBS) screening</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The microflora of maternal blood</measure>
    <time_frame>4-6 weeks after the baby is born</time_frame>
    <description>Use venous blood to collect 20 ml of mother's blood for bacterial analysis.The mother's blood uses Qiagen DNA isolation mini kit to extract DNA, and then uses intestinal bacteria primers to detect the presence of intestinal bacteria in the blood</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic analysis of maternal urine</measure>
    <time_frame>4-6 weeks after the baby is born</time_frame>
    <description>Collect 10 ml of mother's urine for intestinal dysbiosis analysis. Use Qiagen DNA isolation mini kit to extract DNA from the mother's urine, and then use the intestinal bacteria primer to detect the presence of intestinal bacteria in the urine.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bacteria analysis of breast milk</measure>
    <time_frame>4-6 weeks after the baby is born</time_frame>
    <description>Collect 10 ml of breast milk for bacterial phase analysis.Use Qiagen DNA isolation mini kit to extract DNA from breast milk, and then use intestinal bacteria primers to detect whether the breast milk contains intestinal bacteria.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bacteria analysis of infant feces</measure>
    <time_frame>4-6 weeks after the baby is born</time_frame>
    <description>Collect baby feces for bacterial phase analysis.Use Baby feces use Qiagen stool mini kit to extract DNA, and then use intestinal bacteria primers to detect the presence of intestinal bacteria in the feces.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Intestinal Bacteria Flora Disturbance</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>consume 1 sachet per day for 1 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Babyguard® Breast Milk Probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>consume 1 sachet per day for 1 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>consume 1 sachet per day for 1 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Babyguard® Breast Milk Probiotics</intervention_name>
    <description>consume 1 sachet per day for 1 months</description>
    <arm_group_label>Babyguard® Breast Milk Probiotics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 20 years old, pregnant women with non-high-risk pregnancy risk assessed by&#xD;
             obstetricians and gynecologists, healthy mothers and infants with no abnormal&#xD;
             obstetric examination results&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women who have used oral or injectable antibiotics within three months before&#xD;
             delivery, or women who need a cesarean section for any reason during pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Those who are 20 years old and pregnant</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ming Shiang Wu, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ming Shiang Wu, Professor</last_name>
    <phone>23123456</phone>
    <phone_ext>65043</phone_ext>
    <email>mingshaing@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <state>Zhongzheng District</state>
        <zip>100225</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming Shiang Wu, Professor</last_name>
      <phone>23123456</phone>
      <phone_ext>65043</phone_ext>
      <email>mingshaing@ntu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 10, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysbiosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

